Sign inJoin waitlistJoin the waitlist

Borys Hrinczenko

Program Director · McLaren Health Care Corporation

Credentials: · · · · · ·

History

McLaren Health Care Corporation
Present

National Institute of Health 1998
1996–1998
Clinical-National Institutes of Health
1995–1996
Mayo Clinic
1992–1995
SUNY Downstate University Health Sciences University College of Medicine
1988–1992

Research

Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
Breast Cancer Research and Treatment · 2018 · 622 citations
Adjuvant Chemotherapy for Stage II Colon Cancer: A Clinical Dilemma
Review · Journal of Oncology Practice · 2017 · Last of 5 authors · 140 citations
PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed…
Journal of Thoracic Oncology · 2015 · 138 citations

NS
Niket Shah
5 papers · 5 as a resident
SV
Sai Sushrutha Mudupula Vemula
4 papers · 4 as a resident
Shreya Motkur
4 papers · 4 as a resident
Maxwell Akanbi
3 papers · 3 as a resident
Osama MoSalem
3 papers · 1 as a fellow
Adam Bowen
2 papers · 2 as a resident
Ahsan Wahab
2 papers
Anas Al-Janadi
2 papers
DS
David Spigel
2 papers
GR
Griffin Rodgers
2 papers
KG
Keerthi Gullapalli
2 papers · 2 as a resident
Luke Gingell
2 papers